Cytogenetics and Cell Genetics · 2008 · 60 citations · 0 references
Life SciencesGeneticsHematologyCytogeneticsHematopathologyMedical GeneticsChromosomal AbnormalitiesChromosome AberrationsMolecular CytogeneticsMyelodysplastic SyndromesNumerical Chromosome AbnormalitiesStructural Chromosome AbnormalitiesAneuploidy AnalysisChromosomal Copy Number AberrationsCytogenetic AberrationsCytogenetic AbnormalitiesCytogenetics In Hematologic DiseaseDna In Situ HybridizationNumerical Chromosome AberrationsStructural Chromosomal Aberrations
An alphoid repetitive DNA (D8Z2) probe specific for the pericentromeric region of chromosome 8 was used to detect extra copies of chromosome 8 in bone marrow cells obtained from 10 patients with hematological disorders and five controls. Numerical aberrations of chromosome 8 were established by conventional banding techniques. Trisomy 8 was found in four patients with myelodysplastic syndrome (MDS) and three with acute myeloid leukemia (AML). Three additional patients with MDS exhibited an extra chromosome 8 in only one metaphase. In five of the seven trisomy cases, the presence of the trisomy 8 clone was confirmed by in situ hybridization (ISH). In one case of AML with trisomy 8, detected by GTG-banding, no significant numbers of cells containing three spots were found using the alphoid repetitive probe; however, hybridization with a chromosome 8-specific library revealed that the alleged extra chromosome 8 was a translocation chromosome containing only the long arm of chromosome 8. Due to a lack of material, it was not possible to achieve optimal ISH results on the trisomy 8 bone marrow cells of patient 7. In the three MDS patients with a single trisomy 8 metaphase, a slight, albeit significant, increase of trisomy 8 interphase cells was found with ISH. We conclude that this probe is useful for cytogenetic studies. Moreover, ISH, in general, is a powerful tool for precise classification of chromosomal aberrations and can also contribute significantly to the clinical evaluation of patients with hematological disorders.